| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |